Journal
GENES
Volume 13, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/genes13122332
Keywords
CSMD1; cancer; complement system; schizophrenia; Parkinson's disease
Categories
Ask authors/readers for more resources
CSMD1, a tumor suppressor gene, plays important roles in various biological processes including development, complement system, neurodevelopment, and cancer progression. Its association with schizophrenia, Parkinson's disease, and different cancers contributes to the development of new diagnosis and treatment methods.
CUB and Sushi Multiple Domains 1 (CSMD1), a tumour suppressor gene, encodes a large membrane-bound protein including a single transmembrane domain. This transmembrane region has a potential tyrosine phosphorylation site, suggesting that CSMD1 is involved in controlling cellular functions. Although the specific mechanisms of action for CSMD1 have not yet been uncovered, it has been linked to a number of processes including development, complement control, neurodevelopment, and cancer progression. In this review, we summarise CSMD1 functions in the cellular processes involved in the complement system, metastasis, and Epithelial mesenchymal transition (EMT) and also in the diseases schizophrenia, Parkinson's disease, and cancer. Clarifying the association between CSMD1 and the aforementioned diseases will contribute to the development of new diagnosis and treatment methods for these diseases. Recent studies in certain cancer types, e.g., gastric cancer, oesophageal cancer, and head and neck squamous cell carcinomas, have indicated the involvement of CSMD1 in response to immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available